BMS291 Pathophysiology and Pharmacology 1 (8)

This subject explores pathophysiological processes contributing to disease. This subject focuses on pathophysiological processes associated with musculoskeletal, cardiovascular and respiratory dysfunction. Relevant pharmacology is integrated throughout.

Availability

Session 1 (30)
On Campus
Albury-Wodonga Campus
Bathurst Campus
Dubbo Campus
Holmesglen
Port Macquarie Campus
Wagga Wagga Campus
Online
Orange Campus
Session 2 (60)
Online
Orange Campus
Term 2 (15)
Online
Orange Campus

Continuing students should consult the SAL for current offering details: BMS291. Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System

HD/FL

Duration

One session

School

School of Biomedical Sciences

Prerequisites

BMS192 or ( BMS130 and MCR101 )

Incompatible Subjects

BMS101, BMS102, BMS121, BMS122, BMS221, BMS222, BMS231, BMS232

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to:
  • define common pathophysiological and pharmacological terms;
  • describe characteristics and origin of different types of cellular injury;
  • demonstrate an understanding of cellular adaptation to injury;
  • identify the interaction and relative contribution genetic and environmental factors have on health breakdown;
  • describe the characteristics of cancerous cells;
  • describe the four pharmacokinetic processes (absorption, distribution, metabolism and elimination);
  • outline key pharmacodynamic principles (eg agonist and antagonists, receptordrug interactions);
  • describe the involvement of microorganisms in disease;
  • name and describe the actions of the major classes of antimicrobial drugs;
  • describe the consequences of alterations in fluids, electrolytes and acidbase balance;
  • outline the major haematological pathologies and malignancies;
  • describe the pathogenesis of major cardiovascular system dysfunction;
  • describe the aetiology and manifestations of shock;
  • outline the primary pharmacological interventions used in the treatment of cardiovascular disease;
  • describe the pathogenesis of common respiratory dysfunctions;
  • describe use of pharmacological agents in the treatment and management of respiratory pathophysiological states;
  • describe the major types of musculoskeletal pathology including both mechanical and physiological injuries;
  • demonstrate understanding of the origin and main theories of pain; and
  • explain the pharmacological treatment of inflammation and pain.

Syllabus

This subject will cover the following topics:

PATHOPHYSIOOGICAL AND PHARMACOLOGICAL FOUNDATIONS
* Cell injury, adaptation and death
* Pharmacokinetics and pharmacodynamics

GENERAL PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Fluid, electrolyte and acid-base imbalances
* Pain and analgesic agents
* Inflammation and anti-inflammatory agents
* Infectious disease and antimicrobial agents
* Neoplastic disorders and antineoplastic agents

SYSTEMATIC PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Cardiovascular dysfunction (coagulopathy, hypertension, atherosclerosis, dysrhythmias, pump failure) and associated pharmacology
* Respiratory dysfunction (asthma, chronic airways limitation, hypoventilation, pulmonary hypertension) and associated pharmacology
* Musculoskeletal dysfunction (arthritis, osteoporosis, metabolic disorders, muscular dystrophy) and associated pharmacology

Contact

For further information about courses and subjects outlined in the CSU handbook please contact:

Current students

Future students

The information contained in the CSU Handbook was accurate at the date of publication: May 2019. The University reserves the right to vary the information at any time without notice.

Back